Type 2 diabetes trials in United States
393 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleGut Microbiota in Metabolic Surgery
- Where
- Nashville
- Age
- 21 years to 65 years
- People
- 300
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT05000996 - No phaseTaking peopleAdapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
- Where
- Houston
- Age
- 14 years to 16 years
- People
- 40
- Run by
- Baylor College of Medicine
See details and how to joinNCT06943001 - No phaseTaking peoplePATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
- Where
- Houston
- Age
- 12 years to 18 years
- People
- 30
- Run by
- Baylor College of Medicine
See details and how to joinNCT06959901 - No phaseTaking peopleContinuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
- Where
- San Diego
- Age
- 18 years to 45 years
- People
- 45
- Run by
- San Diego State University
See details and how to joinNCT07065721 - Phase 4Taking peoplePermissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Diabetes (PRISM)
- Where
- Columbus
- Age
- 18 years and over
- People
- 44
- Run by
- Ohio State University
See details and how to joinNCT07293715 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Anniston, Baltimore, Bellaire, Birmingham, Boston, Brownsville, Buffalo, Clarksville, Corpus Christi, Dallas, Dayton, Gulfport, Gurnee, Honolulu, Houston, Irvine, Louisville, McAllen, Milwaukee, Minneapolis, Myrtle Beach, Nashville, Needham, New Haven, New Orleans, Portland, Salt Lake City, San Antonio, San Diego, Schaumburg, Shavano Park, Sioux Falls, Skokie, Southlake, Springfield, Tucson, Tulsa, Union City, Walnut Creek, West Chester
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Blackfoot, Brownsville, Clearwater, Columbia, Columbus, Dallas, Decatur, Edinburg, Guntersville, Houston, Irvine, Kansas City, Lake Charles, Lake Forest, Long Beach, Manassas, Metairie, Montclair, Morehead City, New Orleans, Norco, Norman, North Charleston, Oklahoma City, Olive Branch, Pasadena, Pembroke Pines, Pittsburgh, Port Orange, Rancho Cucamonga, Redmond, San Antonio, Sioux Falls, Springfield, Spring Valley, St. Petersburg, Suffolk, Tomball, Tucson, Tulsa, Union City, Washington D.C., Winston-Salem
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Beltsville, Champaign, Chicago, Columbus, Escondido, Fargo, Franklin, Houston, Jacksonville, Kansas City, Las Vegas, Lincoln, Manassas, Oxon Hill, Portland, Renton, Smithfield, Somerset, Statesville, Stockbridge, Walnut Creek, Woodstock
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - Phase 3Taking peopleHome Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Where
- Bowie, Chickasha, Columbus, Dallas, Denison, DeSoto, Greenville, Houston, Johns Creek, McKinney, Meridian, Miami, Morehead City, North Richland Hills, Oak Brook, Orlando, Rochester, San Diego, The Villages, Woodstock
- Age
- 18 years to 99 years
- People
- 230 worldwide
- Run by
- Amgen
See details and how to joinNCT07871409 - Phase 1/2Not yet taking people in United StatesRelacorilant in Patients With Poorly Controlled Type 2 Diabetes and Autonomous Cortisol Secretion
- Where
- San Antonio
- Age
- 18 years to 75 years
- People
- 34
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT07925801 - No phaseTaking peopleAn Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
- Where
- Many Locations
- Age
- 18 years and over
- People
- 50,000 worldwide
- Run by
- Bayer
See details and how to joinNCT06278207 - No phaseTaking peopleLinking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
- Where
- Columbus
- Age
- 18 years and over
- People
- 568
- Run by
- Ohio State University
See details and how to joinNCT05472441 - No phaseTaking peopleUsing Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
- Where
- Dallas
- People
- 800
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06593314 - Early phase 1Enrolling by invitationTruway Diagnostic Tools in Primary Care
- Where
- New York
- People
- 200
- Run by
- Truway Health, Inc.
See details and how to joinNCT07209527 - Phase 3Taking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Albuquerque, Baltimore, Canoga Park, Chicago, Cincinnati, Crystal River, Escondido, Evanston, Evansville, Flint, Greensboro, Houston, Lecanto, Louisville, Miramar, Modesto, New Port Richey, New York, Norfolk, Omaha, Pembroke Pines, Rochester, Sacramento, San Antonio, Skokie, Tustin, Walnut Creek, West Hills, Wilmington
- Age
- 18 years and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Where
- Ammon, Atlanta, Beaumont, Corpus Christi, Decatur, Edinburg, Nashville, Sacramento, San Diego, Shavano Park, Smithfield, Stamford, Syracuse, The Bronx, Topeka, Tulsa, Victoria
- Age
- 10 years to 17 years
- People
- 170 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00 - Phase 3Taking peopleA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
- Where
- Los Angeles, Manassas
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07843485 · EU 2026-526189-25-00 - Phase 3Taking peopleMaridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Where
- Arlington, Miami, Miami Lakes, Pompano Beach, Redmond, San Diego, Winter Park
- Age
- 18 years and over
- People
- 1,300 worldwide
- Run by
- Amgen
See details and how to joinNCT07866066 · EU 2025-523772-22-00 - No phaseNot yet taking people in United StatesCommunity Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health
- Where
- Boynton Beach
- Age
- 18 years and over
- People
- 200
- Run by
- Florida International University
See details and how to joinNCT07918508 - No phaseNot yet taking people in United StatesInter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes
- Where
- Stockton
- Age
- 18 years and over
- People
- 60
- Run by
- University of the Pacific
See details and how to joinNCT07920341 - Phase 2Taking peopleA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Where
- Brownsburg, Dayton, Houston, Lawrenceville, Long Island City, Mesquite, Morehead City, Norman, Ocala, Oviedo, Pennington, Phoenix, Redmond, Rexburg, Round Rock, Santa Ana, Scottdale, Shavano Park, Shelby, Staten Island, Union City, Weslaco, West Seneca, Woodstock
- Age
- 18 years to 75 years
- People
- 200 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Albuquerque, Aurora, Austin, Birmingham, Bridgeport, Canoga Park, Chesterfield, Columbia, Corpus Christi, Cullman, Dallas, Daytona Beach, Delray Beach, Dunwoody, Eatontown, Escondido, Fargo, Fleming Island, Fort Worth, Greenbrae, Greensboro, Hamden, Honolulu, Houston, Indianapolis, Inverness, Jacksonville, Lawrenceville, Lima, Long Beach, Long Island City, Los Alamitos, Los Angeles, Macon, Mesquite, Metairie, Miami, Monroe, Morehead City, Mt. Dora, Mt. Pleasant, New Bedford, Ogden, Pembroke Pines, Pittsburgh, Plano, Portland, San Antonio, Sandy City, Santa Clarita, Skokie, Springfield, Spring Valley, Tucson, Uniontown, Walnut Creek, Warren Township, Wilmington, Winter Park
- Age
- 18 years and over
- People
- 1,035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Atlantis, Birmingham, Boston, Bridgeport, Chapel Hill, Chesterfield, Chicago, Cincinnati, Columbia, Dallas, Doral, Dunwoody, Fleming Island, Gainesville, Greensboro, Houston, Idaho Falls, Irvine, Jacksonville, Kingwood, La Jolla, La Mesa, Lexington, Lima, Miami, Mission, Missouri City, Monroe, Morehead City, Myrtle Beach, New Haven, New York, Phoenix, Pittsburgh, Rolling Hills Estates, Sacramento, Saint Augustine, San Antonio, San Diego, Santa Ana, Scottsdale, Shavano Park, Southfield, Topeka, Troy, Tucson, Tustin, Waltham, Waterbury, Weslaco, West Des Moines, West Palm Beach, Wilmington, Wylie
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - No phaseTaking peopleClinical Decision Support for SGLT2i After AKI in Type 2 Diabetes
- Where
- Minneapolis
- Age
- 30 years to 75 years
- People
- 250
- Run by
- University of Minnesota
See details and how to joinNCT07868666 - Phase 3Taking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Arlington, Aurora, Austin, Dalton, Eunice, Fort Worth, Honolulu, Houston, Indianapolis, Los Alamitos, Los Angeles, Marrero, Midland, Mission, New York, Pembroke Pines, Redmond, San Antonio, St Louis, Tucson, Tyler, Warren Township, Weston
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00